Rich Svinkin
Commercial Innovation AI Lead at Astellas Pharma
Otis, Massachusetts
Overview
Work Experience
Commercial Innovation AI Lead
2024 - Current
Leading AI Innovation in the Commercial Organization of Global Opthalmics & Rare Disease
Partner Baker Hall Capital
2021
Executive Director - AI Product Mgt.
2023 - 2024
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Raised $857,900,000.00 from Hercules Capital and Silicon Valley Bank.
Executive Director - Head of Product Horizon AI
2022 - 2023
Productized Horizon AI for Promotional Material Review Automation - LLM developed by NVS AI Lab for automated Claims and References Mgt. - Leveraged Foundational Models from Microsoft & Open AI - Developed UI Product for NVS editors to accelerate review of inbound draft materials for MAP process readiness - Reduced review time by 5x
Director Digital Health Solutions
2019 - 2022
- Led Horizon AI POC development and testing with NVS Global and US editorial staff - Managed team of data scientists, UI developers and designers, IT infrastructure and Azure Architects and Support Engineers - Horizon was the only commercial use case within the first wave of solutions developed in partnership with Microsoft AI Lab
Sr. Technical Product Mgr.
2018 - 2019
Led Project to develop a Payer behavior prediction algorithm and UI for Retina Practices in the buy and bill space. Algorithm exceeded 95% accuracy on 20k patient claim responses from Payers including MA and Commercial
CEO, Cofounder & Head of Product
2016 - 2019
Walk, get $, jaywalk.me Graduate Boomtown Boulder 5/17
Jaywalk is the best way to discover instant local deals around you.
Cofounder & Head of Product
2015 - 2016
Using Blockchain to disrupt currency exchange and international money transfer
Technical Product Manager - IT Innovation
2013 - 2015
Product Lead for development of a clinical decision support system for Anti Microbial Stewardship in a hospital setting
Product Manager and UX team lead
2011 - 2013
Key leader on the EPP program a company wide, global program delivering a validated portal for global collaboration with Merck’s external partners. EngageZone.Merck.com portal nominated for BIO IT World 2013. Program recognition from Merck CEO, CIO, MRL IT VP.
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.
UX Lead & Product Strategist
2008 - 2011
Lead Product Strategy & UX Design for version 7 of the Design2Launch system for Consumer Products Packaging & Marketing Materials Management
Kodak is a technology company that provides imaging solutions and services for enterprises and consumers.
Raised $1,162,047,018.00 from New York State Department of Labor.
UX Lead
2009 - 2010
UX Lead for Merck Intranet - Sync Portal Redesign
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.
UX Designer & Researcher
2007 - 2008
UX Strategy and Architecture Lead Consultant for Promotional Materials Management Workflow
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.